The trademark application Influenza A ( H5 ) Monovalent Vaccine, Adjuvanted AUDENZ was filed by Seqirus UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). Application under examination.
The application was filed in English (French was selected as the second language).